Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

NCT01517984 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

52

Enrollment

NIH

Sponsor class

Stopped Absence of equipoise on the basis of predetermined stopping rules.

Conditions

Kidney Transplant Recipients

Interventions

DRUG: Tacrolimus (CNI) Withdrawal
DRUG: Standard Immunosuppressive Therapy

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]